Analysis of bulk RNA-seq data from GSE25297 (7 DLBCL tumors vs. 7 adjacent healthy controls) revealed a trend of higher LARS expression in tumor tissues compared to adjacent healthy samples, though this difference did not reach statistical significance (P = 0.061, Fig. 1B). This evidence concerns the gene LARS1 and diffuse large B-cell lymphoma.